Product Description
Atracurium Besilate Injection is indicated as an adjunct to general anaesthesia during surgery to relax skeletal muscles, and to facilitate endotracheal intubation and mechanical ventilation. It is also indicated to facilitate mechanical ventilation in intensive care unit (ICU) patients.
Key Benefits and UsageAtracurium Besylate Injection provides effective skeletal muscle relaxation, crucial for successful surgeries and intubation. Its rapid and predictable onset allows anesthetists to manage acute clinical needs in both adult and pediatric patients when administered by trained healthcare professionals.
Safe Handling and StorageProper storage between 2C and 8C, with protection from light, preserves the drug's potency. Use only by authorized personnel in a medical environment, ensuring accurate dosing and effective patient care. Each glass vial is designed for single use to maintain sterility.
FAQ's of Atracurium Besylate Injection:
Q: How should Atracurium Besylate Injection be administered?
A: Atracurium Besylate Injection must be administered intravenously by a qualified healthcare professional, usually within a hospital or clinical setting. The dosage and rate of administration are determined by a physician based on the individual patient's requirements.
Q: What is the recommended dosage of Atracurium Besylate Injection?
A: The typical initial intravenous dosage ranges from 0.3 to 0.6 mg per kg of body weight, as directed by a physician. Dosage may be adjusted depending on the procedure, patient response, and medical condition.
Q: When is Atracurium Besylate Injection indicated for use?
A: This injection is indicated for facilitation of endotracheal intubation and providing skeletal muscle relaxation during surgical operations or mechanical ventilation in adults and children, as deemed necessary by healthcare providers.
Q: Where should Atracurium Besylate Injection be stored?
A: Store the injection in a refrigerator at 2C to 8C, away from direct light. Ensure the vials remain upright and are used within their 24-month shelf life for maximum effectiveness and safety.
Q: What are the possible side effects of this medication?
A: Potential side effects include skin flushing, hypotension, bronchospasm, and other skin reactions. Patients with known hypersensitivity to the drug or related compounds should not receive this injection.
Q: Who can administer Atracurium Besylate Injection?
A: Only licensed healthcare professionals such as anesthetists, doctors, or trained nurses in hospitals or clinics should administer this medication to ensure patient safety and precise dosing.
Q: What is the primary benefit of using Atracurium Besylate Injection during surgery?
A: Atracurium Besylate provides controlled and reversible muscle relaxation, essential for surgical procedures that require immobilization, thus enhancing safety for both surgical teams and patients.